BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27215067)

  • 1. Laboratory Diagnosis of Factor XIII Deficiency, Routine Coagulation Tests with Quantitative and Qualitative Methods.
    Dorgalaleh A; Kazemi A; Zaker F; Shamsizadeh M; Rashidpanah J; Mollaei M
    Clin Lab; 2016; 62(4):491-8. PubMed ID: 27215067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of factor XIII deficiency.
    Dorgalaleh A; Tabibian S; Hosseini MS; Farshi Y; Roshanzamir F; Naderi M; Kazemi A; Zaker F; Aghideh AN; Shamsizadeh M
    Hematology; 2016 Aug; 21(7):430-9. PubMed ID: 27077776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 2 Methods of Clot Solubility Testing in Detection of Factor XIII Deficiency.
    Dorgalaleh A; Tabibian S; Assadollahi V; Shamsizadeh M; Zareban I; Soori S; Daneshi M
    Lab Med; 2016 Nov; 47(4):283-285. PubMed ID: 27522062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First cases of severe congenital factor XIII deficiency in Southwestern Afghanistan in the vicinity of southeast of Iran.
    Hosseini S; Dorgalaleh A; Bamedi T; Tavakol K; Tabibian S; Naderi M; Alizadeh S; Varmaghani B; Shamsizadeh M; Rahimizadeh A; Ebrahimi S
    Blood Coagul Fibrinolysis; 2015 Dec; 26(8):908-11. PubMed ID: 26226252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor XIII deficiency diagnosis: Challenges and tools.
    Karimi M; Peyvandi F; Naderi M; Shapiro A
    Int J Lab Hematol; 2018 Feb; 40(1):3-11. PubMed ID: 29027765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular diagnosis of factor XIII deficiency, data from comprehensive coagulation laboratory in Iran.
    Gheidishahran M; Dorgalaleh A; Tabibian S; Shams M; Sanei Moghaddam E; Khosravi S; Naderi M; Kahraze S; Lotfi F; Kazeme A; Safa M
    Blood Coagul Fibrinolysis; 2018 Jan; 29(1):87-91. PubMed ID: 29095761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for laboratory diagnosis of factor XIII deficiency.
    Dorgalaleh A; Tabibian S; Hosseini S; Shamsizadeh M
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):361-4. PubMed ID: 26588445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Factor XIII.
    Muszbek L; Katona É; Kerényi A
    Methods Mol Biol; 2017; 1646():277-293. PubMed ID: 28804836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Problems relating to the laboratory diagnosis of factor XIII deficiency: a UK NEQAS study.
    Jennings I; Kitchen S; Woods TA; Preston FE;
    J Thromb Haemost; 2003 Dec; 1(12):2603-8. PubMed ID: 14675096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation studies: prothrombin time, partial thromboplastin time, bleeding time.
    Angelos MG; Hamilton GC
    Emerg Med Clin North Am; 1986 Feb; 4(1):95-113. PubMed ID: 3512249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor XIII Assays and associated problems for laboratory diagnosis of factor XIII deficiency: an analysis of International Proficiency testing results.
    Hsu P; Zantek ND; Meijer P; Hayward CP; Brody J; Zhang X; Smock KJ; Van Cott EM
    Semin Thromb Hemost; 2014 Mar; 40(2):232-8. PubMed ID: 24497117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Validation of an Automated Fluorogenic Factor XIII Activity Assay Based on Isopeptidase Activity.
    Leitner M; Büchold C; Pasternack R; Binder NB; Moore GW
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Factor XIII deficiency: data from multicentre exercises amongst UK NEQAS and PRO-RBDD project laboratories.
    Jennings I; Kitchen S; Menegatti M; Palla R; Walker I; Makris M; Peyvandi F
    Int J Lab Hematol; 2017 Aug; 39(4):350-358. PubMed ID: 28406553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic factor XIII deficiency with normal urea solubility test.
    Sanfelippo MJ; Mazza JJ; Mercier RJ
    Clin Lab; 2014; 60(12):2099-102. PubMed ID: 25651747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro inhibition of factor XIII retards clot formation, reduces clot firmness, and increases fibrinolytic effects in whole blood.
    Jámbor C; Reul V; Schnider TW; Degiacomi P; Metzner H; Korte WC
    Anesth Analg; 2009 Oct; 109(4):1023-8. PubMed ID: 19762725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinico-hematologic profile of factor XIII-deficient patients.
    Bhattacharya M; Biswas A; Ahmed RP; Kannan M; Gupta M; Mahapatra M; Choudhry VP; Saxena R
    Clin Appl Thromb Hemost; 2005 Oct; 11(4):475-80. PubMed ID: 16244775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of blood coagulation factor XIII and FXIII Val34Leu on plasma clot formation measured by thrombelastography.
    Schroeder V; Chatterjee T; Kohler HP
    Thromb Res; 2001 Dec; 104(6):467-74. PubMed ID: 11755957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired Factor Xiii Deficiency: An Uncommon But Easily Missed Cause Of Severe Bleeding.
    Fogarty H; Byrne M; O’Connell NM; Ryan K; White B; O’Donnell JS; Lavin M
    Ir Med J; 2018 May; 111(5):757. PubMed ID: 30489053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of acquired FXIII deficiency with severe bleeding symptoms.
    Hayashi T; Kadohira Y; Morishita E; Asakura H; Souri M; Ichinose A
    Haemophilia; 2012 Jul; 18(4):618-20. PubMed ID: 22356719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agreement between factor XIII activity and antigen assays in measurement of factor XIII: A French multicenter study of 147 human plasma samples.
    Caron C; Meley R; Le Cam Duchez V; Aillaud MF; Lavenu-Bombled C; Dutrillaux F; Flaujac C; Ryman A; Ternisien C; Lasne D; Galinat H; Pouplard C
    Int J Lab Hematol; 2017 Jun; 39(3):279-285. PubMed ID: 28318109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.